Medical Mycology

Article	Citations
Development of in-house ELISA for Scedosporium/Lomentospora serodiagnosis	46
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo	41
Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis	39
P422 EQUAL PCP Score 2022—an ECMM score derived from current guidelines to measure QUAlity of clinical Pneumocystis Pneumonia management	35
S5.1b Antifungal r esistance	34
Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants	32
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India	28
P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?	27
Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018–2022): An observational study	27
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis	27
P216 Rare isolates from subcutaneous mycotic lesions; A study from tertiary care center in Chhattisgarh, India	24
P196 A rare presentation of subcutaneous Entomophthoramycosis	24
P335 Genome plasticity in Candida albicans : acutting-edge strategy for evolution, adaptation, and survival	23
P361 Demystifying the NIH grant application process for international investigators	23
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain	22
S1.3c Diversity and hybridization in Malassezia furfur	21
Prevalence of azole-resistant Aspergillus fumigatus and other aspergilli in the environment from Argentina	21
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis	21
Fungal diagnostics capacity in Malaysia: A survey across 48 laboratories	21
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa	20
P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study	20
Superficial fungal infections in the south of France—is fusariosis the next emergent onychopathy?	20
OUP accepted manuscript	20
P019 A 5-year study on prevalence and molecular determinants of fluconazole -resistance in C. parapsilosis spp. complex	19
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis	18

Knowledge and regulation on fungal contamination of sand and water: Progress report and perspectives	18
Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort	18
A 40-year antifungal susceptibility surveillance of Talaromyces marneffei (1984–2024) at a tertiary hospital in Guangxi, China	17
Novel in vivo observations of luliconazole 5% nail solution for onychomycosis: An ultrastructural study	17
Landscape of in situ cytokine expression, soluble C-type lectin receptors, and vitamin D in patients with recurrent vulvovaginal candidiasis	15
A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole	15
P088 Molecular identification and antifungal susceptibility of pathogenic yeasts from the China Antifungal Resistance Surveillance Trial (CARST-fungi) Study	14
P348 tRNA modifications in Candida virulence	14
P478 Identification of clinical Candida isolates using maldi-tof-ms and their antifungal susceptibility profile—a study from tertiary care pediatric hospital in noida	14
Identification and antifungal susceptibility profile of uncommon yeast species at Fattouma Bourguiba University Hospital in Tunisia	14
P466 Isolation of Cryptococcus neoformans and other yeast from pigeon droppings in Khartoum state, Sudan	13
S3.4e Unraveling the role of DOG genes in a novel alternative pathway of glycerol biosynthesis in Candida albicans and its influence on virulence	13
P192 Investigating the link between pleomorphism and virulence in Cryptococcus	13
S8.3d Characterization of glycosylphosphatidylinositol-linked aspartyl proteases in Candida glabrata: Role in pathogenicity	13
P212 Fatal invasive aspergillosis in a child with Chronic Granulomatous disease; a case report	13
P309 Clonal outbreak of Trichophyton tonsurans causing tinea capitis among wrestlers in Beijing, China	12
P382 Scalp fungal microbiome and sebum composition in males with and without androgenetic alopecia	12
S1.3d The human pathobiont Malassezia furfur secreted protease MfSAP1 regulates cell dispersal and exacerbates skin inflammation	12
P344 Automatic detection of pneumocystis jirovecii in microscope images: adeep learning-based approach	12
S10.4c Successful treatment of mucormycosis in hematological diseases	12
P086 Clinical outcome and in vitro antifungal susceptibility of clinical isolates of rhino-orbito-cerebral mycosis associated with post COVID 19 from North India	12
S10.5c Insight into the role of secondary metabolism in the pathogenesis of Scedosporium apiospermum	12
P148 Emerging and cryptic Aspergillus species isolated from hospitalized patients with underlying primary immunodeficiencies	12
S2.2a African histoplasmosis	12
S9.5d Genotyping of Malassezia species from seborrheic dermatitis/dandruff patients	11
S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surger	11
Effects of the novel mitochondrial targeted compound phosundoxin against Sporothrix globosa : Microbial sensitivity test combined with transcriptomics an	11
S5.5d SARS-CoV-2 associated invasive fungal sinus infections; the Sri Lankan perspective	11
P355 Pitfalls in medical mycology in India	11
Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance	11
Predicting intracranial involvement: Unveiling perineural spread in COVID-19-associated mucormycosis, a novel phenomenon	11
Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens Lis	10
P183 Monitoring of candida colonization in the respiratory tract of COVID-19 cases	10
Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam	10
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis	10
Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia	10
P094 Atypical cutaneous manifestations of sporotrichosis in Brazil	10
Antifungal efficacy of natural antiseptic products against Candida auris	10
P303 An unusual case of isolated gluteal abscess	10
Antibodies against Histoplasma capsulatum and Aspergillus fumigatus among chronic TB patients in Indonesia: a cross-sectional study	10
P345 The relationship between virulence of Candida albicans and environmental oxygen concentration	9
P193 Candidemia in coronavirus disease 2019 patients in a university hospital in Buenos Aires, Argentina	9
Aspergillus sensitisation detection using point-of-care lateral flow assay in moderate to severe asthma	9
P225 Subcutaneous phaeohyphomycosis by Phaeoacremonium species in a renal transplant recipient	9
P114 Clinical and microbiological spectrum of dermatophytosis from a tertiary care institute	9
S5.1d Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis	9
P113 Expression profile of ABC and MFS multi-drug transporter genes in terbinafine- and fluconazole-resistant Trichophyton spp.	9
S4.1d In vitro activity of eight antifungals against 3343 filamentous pathogenic fungi collected during 18 years at the French National Reference Center for invasive mycosis and antifungals	9
P411 Genus specific real-time PCR-a promising technique for rapid diagnosis of fungal keratitis	9
Malassezia japonica isolated from the cerumen of Cercopithecidae and Hylobatidae	9

P291 Aspergillosis: another force to reckon with during COVID-19 times	9
Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality	8
Opaque cell-specific proteome ofCandida albicansATCC 10231	8
Evaluation of a commercial Histoplasma antigen detection enzyme immunoassay for the follow-up of histoplasmosis treatment in people living with HIV from Argentina	8
P018 Susceptibility profile of Candida albicans causing bloodstream infections against azole antifungals over 5 years: A prospective observational study	8
Detection and genotyping of zoonotic microsporidia in the endangered Iberian lynx (Lynx pardinus)	8
P420 Fungal detection by means of HCR using 2D-Covalent Organic Framework Nanosheet	8
P313 A retrospective analysis of COVID-19 - associated Mucormycosis in a tertiary care center in Northern India	8
S6.3d Candida albicans commensalism in the oral mucosa is favored by limited virulence and metabolic adaptation	8
P118 Pentraxin-3 interacts with Aspergillus fumigatus conidia to regulate pro-inflammatory cytokine production	8
Evaluation of direct antifungal susceptibility testing using E-test for four antifungal agents in candidemia patients	8
Evaluation of the PneumoGenius® PCR assay for the diagnosis ofPneumocystispneumonia and the detection ofPneumocystisdihydropteroate synthase mutations in respiratory samples	8
Whole genome characterization of Trichophyton indotineae isolated in Singapore	8
Diagnostic accuracy of a novel lateral flow assay for histoplasmosis	8
Evaluation of interleukin-8 levels in the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies	8
Management of disseminated histoplasmosis in a high-complexity clinic in Cali, Colombia	8
S2.4d Combination antifungal effects of eugenol with voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares	7
Clinical and imaging characteristics of pulmonary cryptococcosis: a comparative analysis of 118 non-AIDS patients in China	7
Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Ne	7
P166 Traumatic implantation keratitis with Schizophyllum commune in Central India	7
Zoonotic Enterocytozoon bieneusi genotypes in free-ranging and farmed wild ungulates in Spain	7
P317 Phaeohyphomycosis caused by Phialophora verrucosa in a patient with CARD9 mutations	7
P414 Diagnostic allele-specific PCR for the identification of Candida auris clades and common resistance mutations	7
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility	7
S5.4d Agrochemicals potentiate multidrug resistance and alter virulence in Cryptococcus neoformans via hitch-hiking effect of aneuploidy	7
S8.1b Is a search and destroy strategy still feasible for Candida auris in South Africa?	7
P256 A rare case of co-infection with Nigrospora oryzae with mucormycosis in an immunocompromised post-COVID patient	7
Risk factors for COVID-19 associated mucormycosis in India: A case control study	7
Performance of Fungitell STAT point-of-care test for the diagnosis of invasive fungal diseases	7
P110 AIRE gene mutation predisposing chronic mucocutaneous Candidiasis in two kids from a Chinese family	7
Dual quantitative PCR assays for the rapid detection of Trichophyton indotineae from clinical samples	7
Clinical characteristics and outcome of invasive fungal sinusitis in children with hematological malignancies	7
S3.5a Contamination in sand and water of sea, lakes, and river beaches: Risk factor for fungal human disease	7
P435 Evaluation of remote triazole capillary blood testing to facilitate remote therapeutic drug monitoring (TDM): A validation study	7
S9.5c Malassezia-host interactions and the Il-23/17 axis	7
Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles	7
P131 Optimization of MTT assay protocol in Pythium insidiosum zoospores incubated together with neutrophils	7
P438 Epidemiology, risk factor analysis and management of invasive Candida auris infections in tertiary care hepatobiliary center in India	7
Significance of differential expression profiles of ABC transporters in azole susceptibility between Cryptococcus gattii VGI and VGII strains	7
A practical approach to investigating nosocomial acquisition of Aspergillus	7
P432 Detection of erg11 gene mutation in fluconazole resistant Candida albicans isolates	6
P502 Mycology lab of the future—slants to sequencing	6
Biochemical characterization and analysis of gene expression of an α-mannosidase secreted by Paracoccidioides brasiliensis	6
Evaluation of an in-house pan-Malassezia quantitative PCR in human clinical samples	6
P391 Research on molecular diagnostic methods and clinical application of common pathogenic dermatophytes in tinea capitis	6
P486 Disseminated Cryptococcosis diagnosed on fine needle aspiration cytology	6
P206 Phenotypic and molecular characterization of emerging Basidiomycete Schizophyllum commune isolated from clinical samples from India	6
P299 A clinicomycological study of suspected mucormycosis in post-COVID patients attending a tertiary care hospital	6
P372 Deciphering transcript isoform switching and utilization in mature biofilm of Candida glabrata through a global transcriptomic approach	6
P233 COVID-19-a ssociated Mucormycosis: an experience of invasive fungal sinusitis from a tertiary care referral center in Northern India	6
P334 Fungal infections in patients with COVID-19 in 1-year pandemic 2020-2021 from Cote d'Ivoire	6
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis–a two-centre observational study	6
A diverse spectrum of mycoses histologically diagnosed in Ghana: Insights from a 10-year retrospective study	6
P223 First case of Candida auris candidemia in Manipur, Northeast India	6
Molecular detection of Enterocytozoon bieneusi in bats from Portugal	6
Thanks to Reviewers	6
S7.4a Vaccine-inducing lung resident CD4 + memory T cells are protective against Cryptococcus gattii infections	6
P068 Inhibition of Candida glabrata biofilm using the combination of a novel antifungal cyclic lipopeptide and azole: An in vitro synergistic approach	6
P273 Diagnostic dilemmas in Pneumocystis pneumonia in case of long COVID -19	6
P501 Aspergillus fumigatus complicates one third of the patients with suspected bronchial asthma or pulmonary tuberculosis: Clinical validation of indigenously developed diagnostic kits	6
Aspergillus fumigatus—a systematic review to inform the World Health Organization priority list of fungal pathogens	5
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022	5
Epidemiology of candidemia during COVID-19 pandemic era in a teaching hospital: A non-concurrent cohort study	5
Exploring virulence attributes in non-Cryptococcus Tremellomycetes	5
P032 Efficacy of novel azole compounds (ATTAF-1 and ATTAF-2) against Candida albicans in a murine model of invasive Candidiasis	5
P294 A descriptive study of Trichosporon fungemia cases from tertiary care center from north India	5
P211 Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units	5
Comparison of PneumID real-time PCR assay with Amplex eazyplex LAMP assay for laboratory diagnosis of Pneumocystis jirovecii Pneumonia	5
Exposure to itraconazole influences the susceptibility to antifungals, physiology, and virulence of Trichophyton interdigitale	5
P057 All- cause mortality in patients with invasive Candidiasis or candidemia from an interim analysis of a Phase 3 Open-label Study (FURI)	5
A notable azole-nonsusceptible Candida orthopsilosis in the Candida parapsilosis complex isolated from onychomycosis in Hue City, Central Vietnam	5
P364 Quantitative monitoring of Aspergillus fumigatus mycelial growth by optical density	5
Mortality patterns in candidemia: Insights from a multispecies analysis using a global research network	5
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis	5
Deep learning for the identification of Candida spp. directly from blood culture gram stains from candidemia patients	5
Cryptococcosis in domestic and wild animals: A review	5
S1.5d Spectrum of etiological agents of mycotic keratitis: A n 11- year review	5
S6.2d Dermatophytosis due to Trichophyton erinacei caused by contact with African hedgehogs as family pets	5
P171 Pneumocystis Jirovecii Pneumonia in non-HIV immunosuppressed patients: Acase series	5
P135 Immunological correlation with clinicomycological aspects of fungal rhinosinusitis during COVID-19 pandemic	5

Coccidioidesspp. exposure among military working dogs in endemic regions of the United States	5
Mucorales: A systematic review to inform the World Health Organization priority list of fungal pathogens	5
Epidemiological shifts of invasive fungal infections in the current era of haematology	5
Identification of four compounds from the Pharmakon library with antifungal activity against Candida auris and species of Cryptococcus	5
KL-6 as a predictor of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) and mortality in critically ill COVID-19 patients: A single-center retrospective cohort study	5
The in vitro activity of iron chelator deferiprone against Candida (Candidozyma) auris in combination with	5
Post-COVID-19 rhino-orbito-cerebral mucormycosis—A clinico-mycological study from North India	5
Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling	5
P078 Baseline antifungal usage patterns and knowledge regarding management of invasive fungal infections as a part of a multidisciplinary antifungal stewardship (AFS) program	5
Routine laboratory screening for cyp51a-related azole resistance in Aspergillus fumigatus using Etest: Concordance with gene sequencing	5
Investigation of invasive fungal infection in tuberculosis/human immunodeficiency virus co-infected patients	5
Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries	5
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections	5
Value of qPCR in the screening strategy for Candida auris	5
Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study	5
P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study	5
S9.1d Chronic pulmonary aspergillosis in post-TB and retreatment TB patients in Lagos, Nigeria	5
Gastrointestinal tract Candida spp colonization shows mostly a monoclonal pattern: an intra-patient pilot study	4
P383 ‘It's not Fungus, its Nocardia’—an elementary diagnostic challenge for draining sinus on abdominal wall (rare): a case report	4
Talaromyces marneffei, Coccidioides species, and Paracoccidioides species—a systematic review to inform the World Health Organization priority list of fungal pathogens	4
Identification of potential targets in bone destruction by Talaromyces marneffei: Insights from data-independent acquisition proteomics	4
P337 Species distribution and biofilm profile of Candida isolated from clinical specimens at a tertiary care hospital in India	4
P370 Low rate of Sporothrix spp. recovery from storage in mineral oil: along period study	4
P417 Evaluation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)-Bruker Biotyper Sirius for identification of invasive molds	4
P251 Disseminated Histoplasmosis in a Ghanaian HIV Patient: Role of Urine Histoplasma Antigen Testing in Rapid Diagnosis	4
Octyl gallate as a treatment for Candida albicans-induced vaginal infection: Effects on fungal burden, inflammation, and Lactobacillus recovery in mice	4
P328 An overexpression screen identifies Csa25 as a novel cellular morphogenesis regulator in the human fungal pathogen Candida albicans	4
Evaluation of simple molecular methods for distinction of the newly emerging dermatophyte Trichophyton indotineae	4
P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples	4
P154 Fungal spore count in a tertiary care hospital in Mumbai, India	4
S1.4d Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis	4
S10.5a Fungal respiratory infections in cystic fibrosis patients in the Middle East	4
P217 Pelvic mycoses— an unusual presentation of Rhizopus arrhizus in an ommunocompetent patient	4
P326 DNA replication initiator proteins stabilize the kinetochore in the human fungal pathogen Cryptococcus neoformans	4
Evaluation of formic acid sandwich (FA-sandwich): A pretreatment method for filamentous fungi, for the identification of clinically relevant filamentous fungi by two MALDI-TOF MS systems	4
High histoplasmosis incidence in kidney transplant recipients in Santa Fe city, Argentina	4
A Falciformispora senegalensis grain model in Galleria mellonella larvae	4
Closing the diagnostic gap in medical mycology: The LODDY Test for identification of Lodderomyces elongisporus	4
P371 The relation of mating type (MAT) preference and source in the opportunistic pathogen Talaromyces marneffei	4
P458 Comparison of PCR protocols for detecting Histoplasma capsulatum and Coccidioides spp. DNA through a multicenter study	4
S9.4c Diverse environmental inputs mediate changes in β-glucan exposure at the Candida albicans cell surface thereby influencing tissue colonisation during systemic infection	4
S6.2b In vitro susceptibility testing of dermatophytes: toward standardization	3
P167 Fungemia in neonatal ICU of a pediatric hospital in NE India	3
The Argentinian landscape of mycological diagnostic capacity and treatment accessibility	3
P268 Laryngeal Mucormycosis: does mucor take the voice away?	3
P138 A decade of cat-transmitted sporotrichosis (CTS) in a tertiary hospital from Curitiba, southern Brazil (2011-21)	3
Deciphering prognostic indicators in non-HIV cryptococcal meningitis: Constructing and validating a predictive Nomogram model	3
Natural history of pulmonary coccidioidomycosis: Further examination of the VA-Armed Forces Database	3
P041 Preliminary evaluation of gradient concentration strips for detection of terbinafine resistance in Trichophyton spp.	3
Metabolic and morphostructural plasticity of environmental and animal strains of Nannizzia gypsea	3
P174 Prevalence and outcomes of patients with COVID - associated mucormycosis (CAM): A case series	3
P484 Expanding VGVI—evidence for distinct Cryptococcus gattii (decagattii) endemic to the American Southwest	3
Clustered cases of Candida auris colonization: Roles of the infection prevention and control department and the mycology laboratory in controlling transmission	3
P427 The value of nasal and oral clinical examination in febrile neutropenic patients for initiating anti-fungal therapy as a preemptive method	3
Association of adverse effects with high serum posaconazole concentrations	3
Experimental Pneumocystis infection in dexamethasone immunosuppressed macaques	3
P106 A dermoscopic finding of Tinea capitis caused by Microsporum canis	3
Malassezia gallinae sp. nov., a new basidiomycetous yeast species isolated from skins of chickens	3
P054 Two effects of curcumin to Candida albicans	3
Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis	3
Interference of Malassezia restricta in the invasion of Staphylococcus aureus into human keratinocytes	3
P269 Managing prosthetic valve endocarditis due to Sarocladium kiliense: Finding a way through uncertainties	3
P426 Interleukins—a non-invasive biomarker for invasive fungal sinusitis	3
P219 Fungal keratitis caused by Pseudallescheria boydii: Clinical and mycological characteristics	3
Candida aurisfrom the Egyptian cobra: Role of snakes as potential reservoirs	3
S7.3d Environmental surveillance of Aspergillus fumigatus in Dutch agricultural crops	3
P162 Parinaud's Oculoglandular Syndrome as an atypical manifestation of sporotrichosis in Brazil	3
P051 A case of recalcitrant sporotrichosis by infection of Sporothrix globosa	3
P195 Factors related to outcome of bloodstream infections due to Candida parapsilosis complex: A single center observation study from Central India	3
Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature	3
P240 Candida nivariensis infection in South East Asia: series of case reports from Selayang Hospital, Malaysia and South East Asia Region	3
Madurella mycetomatis grains within a eumycetoma lesion are clonal	3
P044 Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris	3
The Billirud Mill Blastomycosis Outbreak: Comparison to Historical Controls	3
Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis	3
P075 Initial results of an international effort in screening new agents against Candida auris	3
P213 Lasiodiplodia theobromae: an emerging human pathogen	3
Identification of the cell-surface lectin domain-containing protein expressed in the adhesive colony morphology of Trichosporon asahii	3
P442 Bacterial and fungal infection in COVID-19 diagnosed cases in a tertiary care ICU setting in the wake of second wave in Kolkata, India	3
S4.3b Candida glabrata-host interactions	3
Incidence of invasive fungal infections in patients with hematological malignancies receiving ibrutinib therapy in south-east Austria	3
Invasive mold infection of the gastrointestinal tract: A case series of 22 immunocompromised patients from a single academic center	2
High prevalence of central nervous system cryptococcosis using a fingerprick whole-blood lateral flow assay in individuals with neurological symptoms and advanced HIV disease in a Brazilian emergency	2
P231 The first case of neonatal fungemia caused by Aureobasidium melanogenum	2
Deubiquitination module is critical for oxidative stress response and biofilm formation in Candida glabrata	2
Detection of Blastomyces gilchristii via metagenomic sequencing in outbreak-associated soils	2
Reactive oxygen and nitrogen species are crucial for the antifungal activity of amorolfine and ciclopirox olamine against the dermatophyte Trichophyton interdigitale	2
Development and validation of a new quantitative reverse transcription PCR assay for the diagnosis of human sporotrichosis	2
Comparison of broth microdilution and Etest® methods for susceptibility testing of amphotericin B in Candida auris	2
Clinical characteristics, treatment, and outcome of low-risk non-HIV-associated cryptococcal meningitis: A retrospective cohort study	2
Is milbemycin a game changer against antifungal drug-resistant mycoses?	2
Microbial and clinical epidemiology of invasive fungal rhinosinusitis in hospitalized COVID-19 patients, the divergent causative agents	2
P151 Molecular epidemiology of environmental strains of Cryptococcus isolated from Varanasi, Uttar Pradesh, India	2
Paeonol enhances treatment of fluconazole and amphotericin B against oropharyngeal candidiasis through HIF-1α related IL-17 signaling	2
Immunohistochemical insights into oxidative stress and programmed cell death in primary and COVID-associated rhino-orbital-cerebral mucormycosis patient tissues	2